Cargando…
Central serous chorioretinopathy in primary hyperaldosteronism
PURPOSE: To describe ophthalmological characteristics of 13 patients with primary hyperaldosteronism (PA). METHODS: Cross-sectional study. All patients underwent extensive ophthalmological examination. RESULTS: Thirteen PA patients (9 male, 4 female) were diagnosed with arterial hypertension for 11....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045484/ https://www.ncbi.nlm.nih.gov/pubmed/27393297 http://dx.doi.org/10.1007/s00417-016-3417-8 |
_version_ | 1782457127620575232 |
---|---|
author | van Dijk, Elon H. C. Nijhoff, Michiel F. de Jong, Eiko K. Meijer, Onno C. de Vries, Aiko P. J. Boon, Camiel J. F. |
author_facet | van Dijk, Elon H. C. Nijhoff, Michiel F. de Jong, Eiko K. Meijer, Onno C. de Vries, Aiko P. J. Boon, Camiel J. F. |
author_sort | van Dijk, Elon H. C. |
collection | PubMed |
description | PURPOSE: To describe ophthalmological characteristics of 13 patients with primary hyperaldosteronism (PA). METHODS: Cross-sectional study. All patients underwent extensive ophthalmological examination. RESULTS: Thirteen PA patients (9 male, 4 female) were diagnosed with arterial hypertension for 11.0 ± 11.2 years. Ophthalmological imaging revealed macular serous subretinal fluid (SRF) on optical coherence tomography in 2 patients (15 %). In one of these patients, bilateral chronic central serous chorioretinopathy (CSC) with polypoidal choroidal neovasculopathy was diagnosed, which was effectively treated with full-dose photodynamic therapy. In the other patient with SRF and bilateral diffuse hyperfluorescent areas on fluorescein angiography, the SRF had decreased spontaneously after 6 weeks of follow-up. In 5 of the remaining patients (38 %), retinal pigment epithelium alterations resembling findings characteristic for CSC were seen on multimodal imaging. The mean subfoveal choroidal thickness was 290.2 ± 65.0 μm. CONCLUSIONS: Retinal abnormalities resembling (subclinical) CSC are common in patients with PA. These findings indicate that mineralocorticoid-mediated pathways are involved in the pathogenesis of CSC. In CSC patients with hypertension of unknown origin, a diagnosis of PA should be considered. |
format | Online Article Text |
id | pubmed-5045484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-50454842016-10-15 Central serous chorioretinopathy in primary hyperaldosteronism van Dijk, Elon H. C. Nijhoff, Michiel F. de Jong, Eiko K. Meijer, Onno C. de Vries, Aiko P. J. Boon, Camiel J. F. Graefes Arch Clin Exp Ophthalmol Medical Ophthalmology PURPOSE: To describe ophthalmological characteristics of 13 patients with primary hyperaldosteronism (PA). METHODS: Cross-sectional study. All patients underwent extensive ophthalmological examination. RESULTS: Thirteen PA patients (9 male, 4 female) were diagnosed with arterial hypertension for 11.0 ± 11.2 years. Ophthalmological imaging revealed macular serous subretinal fluid (SRF) on optical coherence tomography in 2 patients (15 %). In one of these patients, bilateral chronic central serous chorioretinopathy (CSC) with polypoidal choroidal neovasculopathy was diagnosed, which was effectively treated with full-dose photodynamic therapy. In the other patient with SRF and bilateral diffuse hyperfluorescent areas on fluorescein angiography, the SRF had decreased spontaneously after 6 weeks of follow-up. In 5 of the remaining patients (38 %), retinal pigment epithelium alterations resembling findings characteristic for CSC were seen on multimodal imaging. The mean subfoveal choroidal thickness was 290.2 ± 65.0 μm. CONCLUSIONS: Retinal abnormalities resembling (subclinical) CSC are common in patients with PA. These findings indicate that mineralocorticoid-mediated pathways are involved in the pathogenesis of CSC. In CSC patients with hypertension of unknown origin, a diagnosis of PA should be considered. Springer Berlin Heidelberg 2016-07-08 2016 /pmc/articles/PMC5045484/ /pubmed/27393297 http://dx.doi.org/10.1007/s00417-016-3417-8 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Medical Ophthalmology van Dijk, Elon H. C. Nijhoff, Michiel F. de Jong, Eiko K. Meijer, Onno C. de Vries, Aiko P. J. Boon, Camiel J. F. Central serous chorioretinopathy in primary hyperaldosteronism |
title | Central serous chorioretinopathy in primary hyperaldosteronism |
title_full | Central serous chorioretinopathy in primary hyperaldosteronism |
title_fullStr | Central serous chorioretinopathy in primary hyperaldosteronism |
title_full_unstemmed | Central serous chorioretinopathy in primary hyperaldosteronism |
title_short | Central serous chorioretinopathy in primary hyperaldosteronism |
title_sort | central serous chorioretinopathy in primary hyperaldosteronism |
topic | Medical Ophthalmology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045484/ https://www.ncbi.nlm.nih.gov/pubmed/27393297 http://dx.doi.org/10.1007/s00417-016-3417-8 |
work_keys_str_mv | AT vandijkelonhc centralserouschorioretinopathyinprimaryhyperaldosteronism AT nijhoffmichielf centralserouschorioretinopathyinprimaryhyperaldosteronism AT dejongeikok centralserouschorioretinopathyinprimaryhyperaldosteronism AT meijeronnoc centralserouschorioretinopathyinprimaryhyperaldosteronism AT devriesaikopj centralserouschorioretinopathyinprimaryhyperaldosteronism AT booncamieljf centralserouschorioretinopathyinprimaryhyperaldosteronism |